David Curtis, MBBS, PhD, FRACP, FRCPA, is an associate professor and head of the Division of Blood Cancer Research of the Australian Centre for Blood Diseases at Monash University, Alfred Hospital

Dr Curtis on Cyclophosphamide GVHD Prophylaxis in Matched Donor Transplant

David Curtis, MBBS, PhD, FRACP, FRCPA, an associate professor and head of the Division of Blood Cancer Research of the Australian Centre for Blood Diseases at Monash University, Alfred Hospital, discussed findings from the phase 3 ALLG BM12 CAST trial (ACTRN12618000505202) investigating post-transplant, cyclophosphamide-containing therapy for graft-vs-host disease prophylaxis in patients undergoing matched sibling donor peripheral blood stem cell transplantation.

Videos

David Curtis, MBBS, PhD, FRACP, FRCPA, discusses the use of post-transplant cyclophosphamide GVHD prophylaxis in matched donor peripheral blood SCT.

David Curtis, MBBS, PhD, FRACP, FRCPA

Articles

Dr Curtis on Cyclophosphamide GVHD Prophylaxis in Matched Donor Transplant